Macrogen, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jan 2032
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 17, 2027The maintenance fee for Data sharing method based on plurality of blockchains (US 10,417,219) comes due Mar 17, 2027. Unpaid by Sep 17, 2027, it lapses early.
- 1 fee due Apr 10, 2027The maintenance fee for DNA extraction method using microwave for next generation sequencing and use thereof (US 11,781,132) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
- 1 fee due Aug 11, 2027The maintenance fee for Bio-information data providing method, bio-information data storing method and bio-information data transferring system based on multiple blockchains (US 10,560,272) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
- 1 fee due Sep 19, 2027The maintenance fee for Therapeutic and diagnostics compositions targeting toll-like receptors and methods thereof (US 11,931,400) comes due Sep 19, 2027. Unpaid by Mar 20, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 8 of 8
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,428,775 | Transformant for production of lactic acid of high optical purity and method for producing lactic acid using the same In force · From the USPTO record | In force | From the USPTO record | |
| US 10,023,855 | Fusion protein comprising C-terminal domain of RET protein and use thereof as a diagnosing marker In force · From the USPTO record | In force | From the USPTO record | |
| US 11,931,400 | Therapeutic and diagnostics compositions targeting toll-like receptors and methods thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,424,006 | Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide In force · From the USPTO record | In force | From the USPTO record | |
| US 10,417,219 | Data sharing method based on plurality of blockchains In force · From the USPTO record | In force | From the USPTO record | |
| US 10,560,272 | Bio-information data providing method, bio-information data storing method and bio-information data transferring system based on multiple blockchains In force · From the USPTO record | In force | From the USPTO record | |
| US 11,004,544 | Method of providing biological data, method of encrypting biological data, and method of processing biological data In force · From the USPTO record | In force | From the USPTO record | |
| US 11,781,132 | DNA extraction method using microwave for next generation sequencing and use thereof In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 1 abandoned · 3 no status recorded